CClinicalTrials.gg
CompletedNCT07822191Updated Sep 16, 2026

The Predictive Value of Chest Trauma Score and Thoracic Trauma Severity Score in Thoracic Trauma Patients

An observational study in Thoracic Trauma and Blunt Trauma, sponsored by Tanta University. Completed at 1 site in Egypt. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-09-16.

Sponsored by Tanta University · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
60
Ages
18 Years to 70 Years
Sex
All
01

Study summary

The aim of this prospective study is Comparing the diagnostic accuracy of chest Trauma Score and Thoracic Trauma Severity Score in predicting morbidity and mortality.

Read the detailed description

Trauma has been recognized as a leading cause of death and disability worldwide over the past few decades. Thoracic trauma is the third most common traumatic death, after head and spinal cord injury. The incidence of chest trauma is reported 10% of trauma admissions and mortality rate is variable ranging from about 10% to 60% . Trauma to thoracic region has a wide spectrum from chest wall injury to vital organs within the thoracic cavity. Thoracic injuries may be penetrating or blunt and management varies from conservative to invasive . Early accurate grading of chest injury severity is decisive for the clinical course of multiple trauma patients. The severity of chest trauma influences decision making in multiple trauma in terms of timing and priority of surgical interventions (early total care versus damage control) in order to avoid posttraumatic complications . Chest trauma can be classified as either blunt or penetrating type. Penetrating chest wounds are those in which an object penetrates the chest wall and creates an opening into the thoracic cavity. These wounds mostly result from stabbings, gunshot wounds and blast injuries . Blunt trauma to the chest occurs as a result of a force that is propelled onto the chest wall but does not leave an open wound. Motor vehicle accidents account for 90% of the entire blunt chest trauma, other possible causes include falls, crush injuries, sports injuries and acts of violence . chest wall injuries typically make breathing very painful; patients often limit inspiration (splinting). A common complication of splinting is atelectasis, which can lead to hypoxemia, pneumonia, or both . The aim of this prospective study is Comparing the diagnostic accuracy of chest Trauma Score and Thoracic Trauma Severity Score in predicting morbidity and mortality.

02

Conditions studied

  • Thoracic Trauma
  • Blunt Trauma

Keywords

  • Thorax Trauma Severity Score
  • chest Trauma Score
  • Trauma
  • Thoracic Trauma Patients
03

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

All chest trauma patients

Inclusion criteria

  • Age ≥18 years old.
  • All chest trauma patients

Exclusion criteria

Exclusion Criteria:

  • Age \< 18 years old.
  • Patients with chest disease
04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
60 participants (actual)
Patient registry
No

Groups and cohorts

  • chest trauma patients

    chest trauma patients

05

What researchers measure

Primary outcomes

  1. The diagnostic accuracy of chest Trauma Score and Thoracic Trauma Severity Score to predict mortality.

    Chest Trauma Scoring (CTS): The Chest Trauma Scoring is composed of four different components with a point system assigned: * Age. * Pulmonary contusion. * Number of rib fractures. * The presence of bilateral rib fracture. The TTSS score includes five parameters (PaO2/FiO2, Rib fractures, Lung contusion, Pleural injuries) and the score ranged from 0 to 25 points.

    Time frame: 18 days

Secondary outcomes

  1. Need and duration of mechanical ventilation

    Time frame: 18 days

06

Study locations

1 site
  • Tanta University
    Tanta, Egypt
07

References and documents

Individual participant data

Plan to share: Yes — it will be available if it needed

Supporting information: Study protocol, Sap, Icf

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07822191
Lead sponsor
Tanta University
Responsible party
Mohamed Ibrahim Mohamed Matar (Assistant lecturer, Tanta University) — Principal investigator
First posted
Sep 16, 2026
Start date
Sep 30, 2023
Primary completion
Oct 30, 2025
Completion
Oct 30, 2025
Last update
Sep 16, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion